2023-2029 Global Oral Anti-allergic Drugs Industry Research & Trends Analysis Report
According to the research report, the global market for Oral Anti-allergic Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Oral Anti-allergic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Oral Anti-allergic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Antihistamine Drugs segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacies has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Oral Anti-allergic Drugs include Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer and AstraZeneca, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Oral Anti-allergic Drugs. Report Highlights:
(1) Global Oral Anti-allergic Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Oral Anti-allergic Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Oral Anti-allergic Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Oral Anti-allergic Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Oral Anti-allergic Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Oral Anti-allergic Drugs, capacity, production and trends.
(7) Oral Anti-allergic Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Antihistamine Drugs
Allergic Mediator Release Agent
Immunosuppressant Drugs
Market segment by application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Sanofi
Johnson & Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Almirall
Pfizer
AstraZeneca
Sun Pharma
Novartis
Boehringer Ingelheim
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays Pharma
1 Market Overview
1.1 Oral Anti-allergic Drugs Definition
1.2 Global Oral Anti-allergic Drugs Market Size and Forecast
1.2.1 By Revenue, Global Oral Anti-allergic Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Oral Anti-allergic Drugs Market Size, 2018-2029
1.2.3 Global Oral Anti-allergic Drugs Price Trend, 2018-2029
1.3 China Oral Anti-allergic Drugs Market Size and Forecast
1.3.1 By Revenue, China Oral Anti-allergic Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Oral Anti-allergic Drugs Market Size, 2018-2029
1.3.3 China Oral Anti-allergic Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Oral Anti-allergic Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Oral Anti-allergic Drugs Share in Global Market, 2018-2029
1.4.3 Oral Anti-allergic Drugs Market Size: China VS Global, 2018-2029
1.5 Oral Anti-allergic Drugs Market Dynamics
1.5.1 Oral Anti-allergic Drugs Market Drivers
1.5.2 Oral Anti-allergic Drugs Market Restraints
1.5.3 Oral Anti-allergic Drugs Industry Trends
1.5.4 Oral Anti-allergic Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Oral Anti-allergic Drugs Revenue by Company, 2018-2023
2.2 Global Oral Anti-allergic Drugs Sales Volume by Company, 2018-2023
2.3 Global Oral Anti-allergic Drugs Price by Company, 2018-2023
2.4 Global Oral Anti-allergic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Oral Anti-allergic Drugs Concentration Ratio
2.6 Global Oral Anti-allergic Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Oral Anti-allergic Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Oral Anti-allergic Drugs Revenue by Company, 2018-2023
3.2 China Oral Anti-allergic Drugs Sales Volume by Company, 2018-2023
3.3 China Oral Anti-allergic Drugs Oral Anti-allergic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Oral Anti-allergic Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Oral Anti-allergic Drugs Domestic VS Export
3.6 China Market, Oral Anti-allergic Drugs Import & Export
3.6.1 China Market, Oral Anti-allergic Drugs Import & Export, 2018-2029
3.6.2 China Oral Anti-allergic Drugs Import & Export Trends
3.6.3 Main Sources of China Oral Anti-allergic Drugs Import
3.6.4 Export Destination of China Oral Anti-allergic Drugs
4 Oral Anti-allergic Drugs Production by Region
4.1 Global Oral Anti-allergic Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Oral Anti-allergic Drugs Manufacturers
4.3 Global Major Manufacturers, Oral Anti-allergic Drugs Capacity Expansion and Future Plans
4.4 Global Oral Anti-allergic Drugs Capacity by Region
4.5 Global Oral Anti-allergic Drugs Production by Region
4.5.1 Global Oral Anti-allergic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Oral Anti-allergic Drugs Production by Region, 2018-2023
4.5.3 Global Oral Anti-allergic Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Oral Anti-allergic Drugs Industry Chain
5.2 Oral Anti-allergic Drugs Upstream Analysis
5.2.1 Oral Anti-allergic Drugs Core Raw Materials
5.2.2 Main Manufacturers of Oral Anti-allergic Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Oral Anti-allergic Drugs Production Mode
5.6 Oral Anti-allergic Drugs Procurement Model
5.7 Oral Anti-allergic Drugs Industry Sales Model and Sales Channels
5.7.1 Oral Anti-allergic Drugs Sales Model
5.7.2 Oral Anti-allergic Drugs Typical Distributors
6 Sights by Type
6.1 Oral Anti-allergic Drugs Classification
6.1.1 Antihistamine Drugs
6.1.2 Allergic Mediator Release Agent
6.1.3 Immunosuppressant Drugs
6.2 By Type, Global Oral Anti-allergic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Oral Anti-allergic Drugs Revenue, 2018-2029
6.4 By Type, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029
6.5 By Type, Global Oral Anti-allergic Drugs Price, 2018-2029
7 Sights by Application
7.1 Oral Anti-allergic Drugs Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Oral Anti-allergic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Oral Anti-allergic Drugs Revenue, 2018-2029
7.4 By Application, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029
7.5 By Application, Global Oral Anti-allergic Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Oral Anti-allergic Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Oral Anti-allergic Drugs Revenue, 2018-2029
8.3 By Region, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Oral Anti-allergic Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Oral Anti-allergic Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Oral Anti-allergic Drugs Market Size Market Share
8.7 South America
8.7.1 South America Oral Anti-allergic Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Oral Anti-allergic Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Oral Anti-allergic Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Oral Anti-allergic Drugs Revenue, 2018-2029
9.3 By Country, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Oral Anti-allergic Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Oral Anti-allergic Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Oral Anti-allergic Drugs Market Size, 2018-2029
9.6.2 By Company, China Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Oral Anti-allergic Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Oral Anti-allergic Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Oral Anti-allergic Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Oral Anti-allergic Drugs Market Size, 2018-2029
9.10.2 By Company, India Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Oral Anti-allergic Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Oral Anti-allergic Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sanofi
10.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.1.2 Sanofi Oral Anti-allergic Drugs Models, Specifications and Application
10.1.3 Sanofi Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sanofi Company Profile and Main Business
10.1.5 Sanofi Recent Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.2.2 Johnson & Johnson Oral Anti-allergic Drugs Models, Specifications and Application
10.2.3 Johnson & Johnson Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Johnson & Johnson Company Profile and Main Business
10.2.5 Johnson & Johnson Recent Developments
10.3 Merck
10.3.1 Merck Company Information, Head Office, Market Area and Industry Position
10.3.2 Merck Oral Anti-allergic Drugs Models, Specifications and Application
10.3.3 Merck Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck Company Profile and Main Business
10.3.5 Merck Recent Developments
10.4 Teva
10.4.1 Teva Company Information, Head Office, Market Area and Industry Position
10.4.2 Teva Oral Anti-allergic Drugs Models, Specifications and Application
10.4.3 Teva Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Teva Company Profile and Main Business
10.4.5 Teva Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
10.5.2 GlaxoSmithKline Oral Anti-allergic Drugs Models, Specifications and Application
10.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 GlaxoSmithKline Company Profile and Main Business
10.5.5 GlaxoSmithKline Recent Developments
10.6 Bayer
10.6.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.6.2 Bayer Oral Anti-allergic Drugs Models, Specifications and Application
10.6.3 Bayer Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bayer Company Profile and Main Business
10.6.5 Bayer Recent Developments
10.7 Almirall
10.7.1 Almirall Company Information, Head Office, Market Area and Industry Position
10.7.2 Almirall Oral Anti-allergic Drugs Models, Specifications and Application
10.7.3 Almirall Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Almirall Company Profile and Main Business
10.7.5 Almirall Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.8.2 Pfizer Oral Anti-allergic Drugs Models, Specifications and Application
10.8.3 Pfizer Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.9.2 AstraZeneca Oral Anti-allergic Drugs Models, Specifications and Application
10.9.3 AstraZeneca Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 AstraZeneca Company Profile and Main Business
10.9.5 AstraZeneca Recent Developments
10.10 Sun Pharma
10.10.1 Sun Pharma Company Information, Head Office, Market Area and Industry Position
10.10.2 Sun Pharma Oral Anti-allergic Drugs Models, Specifications and Application
10.10.3 Sun Pharma Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Sun Pharma Company Profile and Main Business
10.10.5 Sun Pharma Recent Developments
10.11 Novartis
10.11.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.11.2 Novartis Oral Anti-allergic Drugs Models, Specifications and Application
10.11.3 Novartis Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novartis Company Profile and Main Business
10.11.5 Novartis Recent Developments
10.12 Boehringer Ingelheim
10.12.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.12.2 Boehringer Ingelheim Oral Anti-allergic Drugs Models, Specifications and Application
10.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Boehringer Ingelheim Company Profile and Main Business
10.12.5 Boehringer Ingelheim Recent Developments
10.13 UCB Pharma
10.13.1 UCB Pharma Company Information, Head Office, Market Area and Industry Position
10.13.2 UCB Pharma Oral Anti-allergic Drugs Models, Specifications and Application
10.13.3 UCB Pharma Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 UCB Pharma Company Profile and Main Business
10.13.5 UCB Pharma Recent Developments
10.14 Yangtze River Pharmaceutical Group
10.14.1 Yangtze River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.14.2 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Models, Specifications and Application
10.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Yangtze River Pharmaceutical Group Company Profile and Main Business
10.14.5 Yangtze River Pharmaceutical Group Recent Developments
10.15 Hainan Poly Pharm
10.15.1 Hainan Poly Pharm Company Information, Head Office, Market Area and Industry Position
10.15.2 Hainan Poly Pharm Oral Anti-allergic Drugs Models, Specifications and Application
10.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hainan Poly Pharm Company Profile and Main Business
10.15.5 Hainan Poly Pharm Recent Developments
10.16 Chongqing Huapont Pharmaceutical
10.16.1 Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.16.2 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Models, Specifications and Application
10.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Chongqing Huapont Pharmaceutical Company Profile and Main Business
10.16.5 Chongqing Huapont Pharmaceutical Recent Developments
10.17 Dawnrays Pharma
10.17.1 Dawnrays Pharma Company Information, Head Office, Market Area and Industry Position
10.17.2 Dawnrays Pharma Oral Anti-allergic Drugs Models, Specifications and Application
10.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Dawnrays Pharma Company Profile and Main Business
10.17.5 Dawnrays Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Oral Anti-allergic Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oral Anti-allergic Drugs Market Restraints
Table 3. Oral Anti-allergic Drugs Market Trends
Table 4. Oral Anti-allergic Drugs Industry Policy
Table 5. Global Oral Anti-allergic Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Oral Anti-allergic Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Oral Anti-allergic Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Oral Anti-allergic Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Oral Anti-allergic Drugs Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Oral Anti-allergic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Oral Anti-allergic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Oral Anti-allergic Drugs Manufacturers Product Type
Table 13. China Oral Anti-allergic Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Oral Anti-allergic Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Oral Anti-allergic Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Oral Anti-allergic Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Oral Anti-allergic Drugs Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Oral Anti-allergic Drugs Import & Export Trends
Table 19. Main Sources of China Oral Anti-allergic Drugs Import
Table 20. Export Destination of China Oral Anti-allergic Drugs
Table 21. Global Headquarters and Manufacturing Base of Oral Anti-allergic Drugs Manufacturers
Table 22. Global Major Manufacturers, Oral Anti-allergic Drugs Capacity Expansion and Future Plans
Table 23. Global Oral Anti-allergic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Oral Anti-allergic Drugs Production by Region, 2018-2023, (K Units)
Table 25. Global Oral Anti-allergic Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Oral Anti-allergic Drugs Upstream (Raw Materials)
Table 27. Global Oral Anti-allergic Drugs Typical Customers
Table 28. Oral Anti-allergic Drugs Typical Distributors
Table 29. By Type, Global Oral Anti-allergic Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Oral Anti-allergic Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Oral Anti-allergic Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Oral Anti-allergic Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Oral Anti-allergic Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Oral Anti-allergic Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Oral Anti-allergic Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Oral Anti-allergic Drugs Sales Volume Market Share, 2018-2029
Table 39. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 40. Sanofi Oral Anti-allergic Drugs Models, Specifications and Application
Table 41. Sanofi Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sanofi Company Profile and Main Business
Table 43. Sanofi Recent Developments
Table 44. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 45. Johnson & Johnson Oral Anti-allergic Drugs Models, Specifications and Application
Table 46. Johnson & Johnson Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Johnson & Johnson Company Profile and Main Business
Table 48. Johnson & Johnson Recent Developments
Table 49. Merck Company Information, Head Office, Market Area and Industry Position
Table 50. Merck Oral Anti-allergic Drugs Models, Specifications and Application
Table 51. Merck Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck Company Profile and Main Business
Table 53. Merck Recent Developments
Table 54. Teva Company Information, Head Office, Market Area and Industry Position
Table 55. Teva Oral Anti-allergic Drugs Models, Specifications and Application
Table 56. Teva Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Teva Company Profile and Main Business
Table 58. Teva Recent Developments
Table 59. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 60. GlaxoSmithKline Oral Anti-allergic Drugs Models, Specifications and Application
Table 61. GlaxoSmithKline Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GlaxoSmithKline Company Profile and Main Business
Table 63. GlaxoSmithKline Recent Developments
Table 64. Bayer Company Information, Head Office, Market Area and Industry Position
Table 65. Bayer Oral Anti-allergic Drugs Models, Specifications and Application
Table 66. Bayer Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bayer Company Profile and Main Business
Table 68. Bayer Recent Developments
Table 69. Almirall Company Information, Head Office, Market Area and Industry Position
Table 70. Almirall Oral Anti-allergic Drugs Models, Specifications and Application
Table 71. Almirall Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Almirall Company Profile and Main Business
Table 73. Almirall Recent Developments
Table 74. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 75. Pfizer Oral Anti-allergic Drugs Models, Specifications and Application
Table 76. Pfizer Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Pfizer Company Profile and Main Business
Table 78. Pfizer Recent Developments
Table 79. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 80. AstraZeneca Oral Anti-allergic Drugs Models, Specifications and Application
Table 81. AstraZeneca Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. AstraZeneca Company Profile and Main Business
Table 83. AstraZeneca Recent Developments
Table 84. Sun Pharma Company Information, Head Office, Market Area and Industry Position
Table 85. Sun Pharma Oral Anti-allergic Drugs Models, Specifications and Application
Table 86. Sun Pharma Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Sun Pharma Company Profile and Main Business
Table 88. Sun Pharma Recent Developments
Table 89. Novartis Company Information, Head Office, Market Area and Industry Position
Table 90. Novartis Oral Anti-allergic Drugs Models, Specifications and Application
Table 91. Novartis Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Novartis Company Profile and Main Business
Table 93. Novartis Recent Developments
Table 94. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 95. Boehringer Ingelheim Oral Anti-allergic Drugs Models, Specifications and Application
Table 96. Boehringer Ingelheim Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Boehringer Ingelheim Company Profile and Main Business
Table 98. Boehringer Ingelheim Recent Developments
Table 99. UCB Pharma Company Information, Head Office, Market Area and Industry Position
Table 100. UCB Pharma Oral Anti-allergic Drugs Models, Specifications and Application
Table 101. UCB Pharma Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. UCB Pharma Company Profile and Main Business
Table 103. UCB Pharma Recent Developments
Table 104. Yangtze River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 105. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Models, Specifications and Application
Table 106. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Yangtze River Pharmaceutical Group Company Profile and Main Business
Table 108. Yangtze River Pharmaceutical Group Recent Developments
Table 109. Hainan Poly Pharm Company Information, Head Office, Market Area and Industry Position
Table 110. Hainan Poly Pharm Oral Anti-allergic Drugs Models, Specifications and Application
Table 111. Hainan Poly Pharm Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Hainan Poly Pharm Company Profile and Main Business
Table 113. Hainan Poly Pharm Recent Developments
Table 114. Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 115. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Models, Specifications and Application
Table 116. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Chongqing Huapont Pharmaceutical Company Profile and Main Business
Table 118. Chongqing Huapont Pharmaceutical Recent Developments
Table 119. Dawnrays Pharma Company Information, Head Office, Market Area and Industry Position
Table 120. Dawnrays Pharma Oral Anti-allergic Drugs Models, Specifications and Application
Table 121. Dawnrays Pharma Oral Anti-allergic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Dawnrays Pharma Company Profile and Main Business
Table 123. Dawnrays Pharma Recent Developments
List of Figure
Figure 1. Oral Anti-allergic Drugs Picture
Figure 2. By Revenue, Global Oral Anti-allergic Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Oral Anti-allergic Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Oral Anti-allergic Drugs Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Oral Anti-allergic Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Oral Anti-allergic Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Oral Anti-allergic Drugs Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Oral Anti-allergic Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Oral Anti-allergic Drugs Share of Global Market, 2018-2029
Figure 10. Global Oral Anti-allergic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Oral Anti-allergic Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Oral Anti-allergic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Oral Anti-allergic Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Oral Anti-allergic Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Oral Anti-allergic Drugs Domestic VS Export, 2022
Figure 16. Global Oral Anti-allergic Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Oral Anti-allergic Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Oral Anti-allergic Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Oral Anti-allergic Drugs Industry Chain
Figure 20. Oral Anti-allergic Drugs Procurement Model
Figure 21. Oral Anti-allergic Drugs Sales Model
Figure 22. Oral Anti-allergic Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Antihistamine Drugs
Figure 24. Allergic Mediator Release Agent
Figure 25. Immunosuppressant Drugs
Figure 26. By Type, Global Oral Anti-allergic Drugs Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Oral Anti-allergic Drugs Revenue Market Share, 2018-2029
Figure 28. By Type, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Oral Anti-allergic Drugs Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Oral Anti-allergic Drugs Price, 2018-2029, (US$/Unit)
Figure 31. Hospital Pharmacies
Figure 32. Retail Pharmacies
Figure 33. Online Pharmacies
Figure 34. By Application, Global Oral Anti-allergic Drugs Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Oral Anti-allergic Drugs Revenue Market Share, 2018-2029
Figure 36. By Application, Global Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Oral Anti-allergic Drugs Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Oral Anti-allergic Drugs Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Oral Anti-allergic Drugs Revenue Market Share, 2018-2029
Figure 40. By Region, Global Oral Anti-allergic Drugs Sales Volume Market Share, 2018-2029
Figure 41. North America Oral Anti-allergic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Oral Anti-allergic Drugs Revenue Market Share, 2022
Figure 43. Europe Oral Anti-allergic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Oral Anti-allergic Drugs Revenue Market Share, 2022
Figure 45. Asia Pacific Oral Anti-allergic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Oral Anti-allergic Drugs Revenue Market Share, 2022
Figure 47. South America Oral Anti-allergic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Oral Anti-allergic Drugs Revenue Market Share, 2022
Figure 49. Middle East & Africa Oral Anti-allergic Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Oral Anti-allergic Drugs Market Share, 2022
Figure 52. By Type, U.S. Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Oral Anti-allergic Drugs Market Share, 2022
Figure 56. By Type, Europe Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 58. China Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Oral Anti-allergic Drugs Market Share, 2022
Figure 60. By Type, China Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Oral Anti-allergic Drugs Market Share, 2022
Figure 64. By Type, Japan Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Oral Anti-allergic Drugs Market Share, 2022
Figure 68. By Type, South Korea Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Oral Anti-allergic Drugs Market Share, 2022
Figure 72. By Type, Southeast Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 74. India Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Oral Anti-allergic Drugs Market Share, 2022
Figure 76. By Type, India Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Oral Anti-allergic Drugs Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Oral Anti-allergic Drugs Market Share, 2022
Figure 80. By Type, Middle East & Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Oral Anti-allergic Drugs Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|